Publication | Closed Access

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

InflammationAutoimmune DiseaseImmunotoxicologyImmunologyImmunoeditingCell DeathImmune Checkpoint InhibitorAutoimmunityImmunotherapyMedicine